Download Where competence accumulates

Where competence
accumulates
The Meilahti Campus
1.
Biomedicum Helsinki 1
2.
Biomedicum Helsinki 2
3.
Biomedicum Helsinki 3 (under planning)
4.
Haartman Institute
5.
National Library of Health Sciences
6.
Meilahti Tower Hospital
7.
Hospital for Children and Adolescents
8.
Children’s Castle
9.
Department of Obstetrics
and Gynaecology
19
20
10. Department of Othorhinolaryngology
and Ophtalmology
11. Department of Oncology
12. Haartman Hospital
13. Meilahti Triangle Hospital
14. Finnish Institute of Occupational Health
15. Helsinki Metropolia University of
Applied Sciences
16. Institute of Dentistry
17. Hjelt Institute
18. National Institute for Health and Welfare
19. HUS Administration
20. Department of Sports and
Exercise Medicin
20. Folkhälsan: Public Health
Research Program
a
Pa
si
en
k iv
ka
tu
Where competence accumulates
The Meilahti Campus
The Meilahti Campus is a nationally as well as
internationally important center for medicine,
health, and well-being. Its strength is in bringing together professionals from various institutions – universities, hospitals, research institutes, universities of applied sciences, and business organizations – to reach shared goals.
Specialist organizations based on the campus produce data and expertise for application
by society to tackle the major challenges for
health care and well-being.
In addition to close collaboration with each
other, the on-campus organizations cooperate
with off-campus specialist organizations, research institutions, institutions of higher education, and business organizations. The international research collaboration is lively and
rapidly expanding.
The major background organizations and
sponsors financing research and education on
the Meilahti Campus include the Finnish government and municipalities, various foundations, actors in Finnish business life, the European Union, the Academy of Finland, the Finnish Innovation Fund Sitra, and Tekes.
JOHAN LUNDIN, SENIOR LECTURER, FROM THE INSTITUTE FOR
MOLECULAR MEDICINE FINLAND FIMM EXAMINES TISSUE
CHANGES ON THE MULTITOUCH MICROSCOPE’S SCREEN.
THE PRINCIPLES OF USE ARE BASED ON WEB MICROSCOPY
DEVELOPED BY LUNDIN AND HIS COLLEAGUES AND A GIGANTIC
MULTITOUCH DISPLAY, ANOTHER FINNISH INNOVATION.
THE MEILAHTI CAMPUS 1
”
Versatile expertise
and top-level medi-
cal research gravitate to
the scientific community
of the Meilahti Campus.
Biomedicum Helsinki
perfectly demonstrates
how important large and
multidisciplinary operating environments are for
BORIS VASSILEV, RESEARCHER,
ATTENDING A LABORATORY MEETING AT
THE INSTITUTE OF BIOMEDICINE AT THE
UNIVERSITY OF HELSINKI
research and education.
A high-quality research
Biomedicum Helsinki
www.biomedicum.fi
Biomedicum Helsinki, a center for medical research and training, offers a unique environment for cooperation among the personnel involved in the university’s medical education, research training, graduate studies, basic medical
research, clinical research conducted by the Helsinki University Central Hospital, and business
organizations. The center offers specialized facilities and services promoting cooperation and
contributing to fruitful interaction.
In addition to the research community comprising the University of Helsinki and the Hospital District of Helsinki and Uusimaa (HUS), other
organizations operating at Biomedicum Helsinki include the Institute for Molecular Medicine
Finland (FIMM), the National Institute of Health
and Welfare, the Folkhälsan Research Center,
2 THE MEILAHTI CAMPUS
support system with common facilities and shared
imaging and DNA/RNA
sequencing and analysis
services has been estab-
the Minerva Foundation Institute for Medical
Research, the Centre for Military Medicine, and
related business organizations. And, from the
beginning of 2013, the Wihuri Research Institution too will be found at Biomedicum Helsinki.
The Biomedicum Helsinki premises are
owned and maintained by Real Estate Company Biomedicum Helsinki.
The Biomedicum Helsinki Foundation is a
background organization supporting young researchers by granting scholarships from funds
donated to the foundation, which further improves the center’s operation environment.
lished through cooperation.
Clinical investigators
and basic scientists are
engaged in research work
in close collaboration, and
whenever a research group
is faced with a challenge, a
specialist to provide expertise is never far away.”
Olli A. Jänne, Professor, Director,
University of Helsinki and
Biomedicum Helsinki
Research yields information >>
”
”
400 people, were selected via a competition. With its
Campus. Under authorization from the Hospital District
annual budget of 17 million euros, it is the university’s
of Helsinki and Uusimaa, the institute is further respon-
largest units. The research programs focus on six fields
sible for the administration of research commissions,
in which the Meilahti Campus showcases its core com-
including agreements and finances. For fellowship
petencies: cancer, inflammatory diseases, metabolic
researchers at HUS, we offer accounting services. We
disorders, degenerative diseases, psychiatric disorders,
support high-quality, ethically approved research work
and cardiovascular diseases. On the Meilahti Campus,
subject to permission and conducted according to the
the research groups engaged in basic research network
international principles of good clinical practice. Most of
with clinics to apply the results in practice as soon as
the clinical studies receiving support from the institute
possible for the patients’ benefit. For young, talented
are early-stage drug development studies in which com-
scientists, the university offers a path to permanent
petence at the level of a university hospital is required
posts (of associate professor to professor) upon as-
and the focus is on drug safety and efficacy. Most new
sessment of accomplishments. Senior researchers can
drugs are developed for the treatment of cancers. We
apply for research faculty membership. Currently, the
make contracts for 120 to 150 new research projects
research faculty include 400 heads of groups.”
each year with partners that are international pharma-
Hannu Sariola, Professor of Developmental Biology, Dean of
Research, Chief Physician, University of Helsinki and HUSLAB
ceutical companies. Currently, there are approximately
The Research Programs Unit is the Faculty of Medicine’s main investment in top-level research. Five
research programs, employing, in total, approximately
Clinical Research Institute Helsinki University
Central Hospital Ltd provides commercial research
services to the researchers working on the Meilahti
400 ongoing projects. Long term projects may last over a
decade, with budgets reaching a million euros.”
Seppo Pakkala, Managing Director, Clinical Research Institute
HUCH Ltd
RESEARCHERS OF MOLECULAR CANCER BIOLOGY
STRIVE TO UNDERSTAND THE MECHANISMS
UNDERLYING CANCER DEVELOPMENT AND TO FIND
METHODS TO STOP THE DEVELOPMENT PROCESS.
JAANA MUSTONEN, RADIOLOGIC
NURSE, IS PREPARING A PATIENT FOR
GAMMA-RAY IMAGING AT THE HUCH
DEPARTMENT OF ONCOLOGY.
THE MEILAHTI CAMPUS 3
”
Research at the Biomedicum Stem Cell
Centre (BSCC) is focused on pluripotent stem
cells. Induced pluripotent stem cells, or iPS cells,
are derived – by means of the latest stem-cell
technologies – from the patient’s own skin or
blood cells. The iPS cells are similar to embryonic
stem cells being able to differentiate into cells of
any type. They are employed to create models of
human cells and tissues that are otherwise impossible to obtain, such as neurons, brain cells,
and myocardial cells. This opens a whole new
avenue for investigating disease mechanisms
at cellular level, exploring how genetic changes
actually lead to the disease, and perhaps finding
a cure for patients with genetic diseases.”
Timo Otonkoski, Professor of Medical Stem Cell Research,
Chief Physician
TIMO OTONKOSKI, PROFESSOR, CHIEF
PHYSICIAN, BIOMEDICUM STEM CELL CENTER
(BSCC), UNIVERSITY OF HELSINKI AND HUCH
CHILDREN’S HOSPITAL
”
The brain is a highly plastic organ, changing
from one moment to the next. Several, very
different methods are applied in brain research
to generate accurate data on brain structure and
function. Transcranial magnetic stimulation can
be targeted at a specific region of the brain for
determination of whether the area is involved in
remembering, for example.”
Synnöve Carlson, Professor of Physiology
SYNNÖVE CARLSON, PROFESSOR, THE INSTITUTE
OF BIOMEDICINE AT THE UNIVERSITY OF HELSINKI
4 THE MEILAHTI CAMPUS
>> Research yields information
”
Biobanks are turning into biodata banks
– a tissue sample is analyzed and broken
down into bits, after which data alone are
processed. Sequencing the whole genome will
soon be routine in diagnostics and research.
We now focus not on one or two genes but
on the entire genome. Combining the results
from molecular profiling with information on
the patient’s disease provides an accurate
overview of the patient’s condition. However,
this is possible only with high-quality patient
samples and a structured and well-documented sampling process. In cooperation with
the National Institute for Health and Welfare,
we have established a modern sample storage
and management facility at the Institute of
Molecular Medicine Finland. The facility will
first be used in the hematology and urology
biobank projects. Of course, everything must
take place only with the patient’s consent –
and always will.”
Kimmo Pitkänen, Head of Development
KIMMO PITKÄNEN, HEAD OF
DEVELOPMENT, INSTITUTE FOR
MOLECULAR MEDICINE FINLAND FIMM
”
The connection between oral infections and
an elevated risk of cardiovascular diseases
was discovered on the Meilahti Campus, in
1989. Work in this field is continued at the
Institute of Dentistry, where my research group
focuses on the role of periodontopathogenic
bacterial species in the onset and development
of cardiovascular diseases. In addition to topical inflammation, periodontitis causes a lowgrade systemic inflammatory response. Pathogens enter the circulation from infected gingival
pockets when the patient eats or brushes the
teeth. If periodontitis goes untreated, the patient is exposed to pathogens on a daily basis
and often for a long time. We are doing basic
research, but we also develop analysis methods
that can be applied in epidemiological studies
and clinical examinations to determine expo-
PIRKKO PUSSINEN, DOCENT, AND KATI HYVÄRINEN,
DOCTORAL STUDENT, INSTITUTE OF DENTISTRY AT
THE UNIVERSITY OF HELSINKI
sure to these pathogens.”
Pirkko Pussinen, Docent of Medical Biochemistry
THE MEILAHTI CAMPUS 5
Information becomes competence
”
Each year, 120 medical and 50 dental students begin their studies at the
Faculty of Medicine at the University of Helsinki. We offer specialized
studies in 49 medical fields, and nearly 40% of Finnish medical specialists have
completed their studies on the Meilahti Campus. The staff also organize specific
training and graduate studies for physicians and dentists, and we offer 37
separate two-year special training programs, in fields such as intensive-care
medicine, pediatric allergology, and reproductive medicine. The Faculty of Medicine also offers a two-year master’s-degree program in translational medicine.
The University of Helsinki is the only university in Finland that offers medical
and dental studies in Swedish also; both of Finland’s national languages are
supported here. Education is organized in cooperation with the Hospital District
of Helsinki and Uusimaa. Practicing physicians give lectures, and lecturers also
practice medicine. The learning environment is based on interaction, and several
forms of social media are employed. Students are given the opportunity to practice with virtual patients over the Internet and with simulations enabling the
practice of manual skills.”
Anne Pitkäranta, Professor of Otorhinolaryngology, Dean of Education, Chief Physician,
University of Helsinki and HUCH Department of Otorhinolaryngology
JULIA DÖHLA IS STUDYING FOR
HER MASTER’S DEGREE IN
TRANSLATIONAL MEDICINE AND
WORKS IN THE MINERVA MEDICAL
RESEARCH CENTRE.
MIKKO KATAJA, ARBER MEHMETI AND AKU
OJANEN ARE SECOND YEAR MEDICAL STUDENTS
PRACTICING MEASURING LUNG FUNCTION.
6 THE MEILAHTI CAMPUS
>>
TUULI OINONEN AND OONA PARONEN STUDY
NURSING AND ARE PRACTICING THEIR SKILLS AT
HELSINKI METROPOLIA UNIVERSITY OF APPLIED
SCIENCES CLINICAL SKILLS CENTRE SKILLSPRO.
”
The Helsinki Metropolia University of
Applied Sciences is in the middle of
a campus where everyone takes health
care and caring for the patient to heart.
Only a short distance away, we are readily
available to give and receive expert advice.
Metropolia’s modern facilities are used in
simulation training wherein medical students can practice patient care safely in a
natural environment.”
Taru Ruotsalainen, Development Manager, Helsinki
Metropolia University of Applied Sciences
”
I study growth factors in blood and
ALEKSANTERI ASPELUND AND MAIJA BRY ARE
GRADUATE SCHOOL RESEARCH STUDENTS
WORKING UNDER THE GUIDANCE OF LABORATORY
COORDINATOR TAPIO TAINOLA IN THE
LABORATORY OF MOLECULAR CANCER BIOLOGY.
lymphatic vessels at Kari Alitalo’s
laboratory in the research program in
molecular cancer biology. It seems that
Schlemm’s canal, which is critical for the
outflow of aqueous humor from the eye,
is a lymphatic vessel. An occlusion in
Schlemm’s canal may be related to increased intraocular pressure, which causes
glaucoma. Since there are no other lymphatic vessels in the eye, my vision is that
one day the differences in lymphatic and
blood vessels can be exploited to target
glaucoma treatment at Schlemm’s canal.”
Aleksanteri Aspelund, Student at Helsinki
Biomedical Graduate School at the University of
Helsinki
THE MEILAHTI CAMPUS 7
Health is in good hands >>
”
Although the cause of type 1 diabetes is not fully
understood, we learn new things about the disease
every day. There is a genetic susceptibility to diabetes,
but some bacteria in the body and in the environment
seem to prevent the disease from developing. To stop
the process leading to diabetes, we are developing a
therapy based on the protective effects of an intestinal
bacterium belonging to the Clostridium leptum subgroup
in cooperation with VTT Technical Research Centre of
Finland. We are also studying whether bovine milk proteins increase the risk of diabetes in children.”
Mikael Knip, Professor of Pediatrics, Chief Physician of Pediatrics
MIKAEL KNIP, PROFESSOR, CHIEF
PHYSICIAN, UNIVERSITY OF HELSINKI
AND HUCH CHILDREN’S HOSPITAL
”
Each minute of hypoxia results in the death of thousands of neurons in the brain. Hence, the treatment of
acute cerebral infarction must be fine-tuned to perfection.
The objective is successful thrombolytic treatment. At
Biomedicum Helsinki, my research group studies the effects of thrombolytic treatment and strives to determine
why vascular permeability increases with cerebral embolus
dissolution, even causing hemorrhages. Another line of
research includes determination of the changes in gene
expression that cause symptomatic conversion of carotid
artery disease, and the use of genetic profiles as biomarkers to identify patients at risk.”
Perttu Lindsberg, Professor of Applied Neurology,
Chief Physician of the Department of Neurology
8 THE MEILAHTI CAMPUS
PERTTU LINDSBERG,
PROFESSOR, CHIEF PHYSICIAN,
UNIVERSITY OF HELSINKI AND
THE HUCH DEPARTMENT OF
NEUROLOGY
”
ARI HARJULA, PROFESSOR, CHIEF
PHYSICIAN, UNIVERSITY OF HELSINKI
AND HUCH DEPARTMENT OF
CARDIOTHORACIC SURGERY
In the future, cardiac operations will be less invasive and more
effective. Treatment methods will be combined, and experts in
diverse fields will collaborate to finish the job. Cardiac deficiencies and
diseases will be treated with small yet effective mechanical hearts and
equipment that penetrates the skin and is carried to the arteries and
eventually to the heart or is inserted in the heart through a small incision between the ribs. Tissue damaged in myocardial infarction can be
repaired by means of the patient’s own stem cells, injected or inserted
into the affected region. Robots are already used in mini-invasive cardiac surgeries to treat valve disorders and coronary artery stenosis.”
Ari Harjula, Professor of Thoracic and Cardiovascular Surgery, Chief Physician of
Department of Cardiothoracic Surgery
THE MEILAHTI CAMPUS 9
>> Health is in good hands
”
At the Department of Oncology, we have a separate unit for radionucleide therapies. In radionucleide therapy, the radioactive element
is carried via the bloodstream to the metastases, where it becomes
attached to cancer cells and starts destroying the tissue. Lutetium-177
octreotate therapy is a new and effective method to combat metastasized neuroendocrine tumors. Yttrium radioembolization is used to treat
liver metastases. Radiation-emitting yttrium-90 microspheres are delivered to the branches of the hepatic arteries, where they block the vessels nourishing the tumor and destroy the tumorous tissue via radiation.
In the latest form of radionucleide therapy, radium-23 chloride therapy,
metastases to the bone are destroyed by extremely short-range alpha
radiation. There is ongoing international research aimed at determining
the efficacy of these therapies, and we at the Department of Oncology
are part of this research. The efficacy of cancer treatments must be
backed-up by reliable, unambiguous scientific evidence.”
Hanna Mäenpää, Docent of Oncology, Chief Physician in the Department of Oncology
HANNA MÄENPÄÄ, DOCENT, CHIEF
PHYSICIAN IN DEPARTMENT
OF ONCOLOGY, UNIVERSITY OF
HELSINKI AND HUCH DEPARTMENT
OF ONCOLOGY
”
We currently have fascinating new tools that will revolutionize
the diagnosis and treatment of cancer. The genomes of cancer
cell clones can be determined base by base. The focus is on identifying the key mutations causing cells to become cancerous and
affecting their survival. The number of these mutations is limited,
and by interfering with these processes we will be able to affect the
development of the disease. For example, KIT may be a driver mutation in acute myeloid leukemia (an aggressive cancer of the blood),
gliomas (hard to treat glial tumors of the brain), and malignant
stromal tumors of the gastrointestinal tract. In the next few years,
cancer typing will be based on individual key mutation profiles.
Diseases sharing the same driver mutation will be treated with the
same drugs, irrespective of the location of the tumor. Storing patient
samples in a biobank and actively studying the samples is now more
important than ever.”
Kimmo Porkka, Professor of Clinical Hematology,
Chief Physician of the Division of Hematology
10 THE MEILAHTI CAMPUS
KIMMO PORKKA, PROFESSOR,
CHIEF PHYSICIAN, UNIVERSITY
OF HELSINKI AND HUCH
DIVISION OF HEMATOLOGY
University of Helsinki
Faculty of Medicine
www.med.helsinki.fi
The University of Helsinki was founded in 1640
and is today a leading European research university. The Faculty of Medicine of the University of Helsinki is among the top actors in its field.
The Faculty of Medicine is home to internationally esteemed research projects and trains phy-
sicians, dentists, and researchers. It produces
scientific research data for the use of decisionmakers, organizations, and private citizens.
The budget of the Faculty of Medicine is under 80 million euros a year, with competitive external funding accounting for 36 million euros of
>>
THE DOCTORAL DISSERTATION OF PIRKKA
VIKATMAA, LICENTIATE OF MEDICINE, SHEDS LIGHT
ON CAROTID SURGERY.
THE MEILAHTI CAMPUS 11
LOTTA VEISTINEN, DOCTORAL
STUDENT, INSTITUTE OF DENTISTRY
AT THE UNIVERSITY OF HELSINKI
>>
this. The Faculty of Medicine has approximately
1,000 employees, mainly in research and teaching posts. In addition to approximately 10 master’s degrees, approximately 140 physician’s
and 30 to 40 dentist’s qualifications are earned
each year. Annually, more than 200 specialists
in medicine and dentistry graduate, 110 to 130
doctorates are earned, and 2,400 scientific articles authored by the researchers at the faculty
are published.
Terkko is the library on the Meilahti Campus
and part of the Helsinki University Library. Terkko provides information services to the Faculty
of Medicine and the Helsinki University Central
Hospital while operating also as the Information
Service Centre for the World Health Organization
in Finland. Terkko offers medical and health-related information to students, researchers, physicians, health-care workers, and anyone with an
interest in health-related topics.
www.helsinki.fi/kirjasto/terkko/
12 THE MEILAHTI CAMPUS
Hospital District
of Helsinki and
Uusimaa
www.hus.fi
RAIJA KLEMOLA, NURSE, TAKES A BLOOD SAMPLE
FROM AKU LESKINEN WHO IS VISITING THE
POLICLINIC AT THE HUCH CHILDREN’S HOSPITAL
WITH HIS FATHER JARMO LESKINEN.
The Hospital District of Helsinki and Uusimaa (HUS) is owned by the municipalities in
Uusimaa and provides specialized medical
care for the 1.5 million residents of its member
municipalities. Each year, roughly half a million
Finnish citizens are treated in the 21 HUS hospitals and clinics.
Eight of these are on the Meilahti Campus:
the Skin and Allergy Hospital, the Children’s Castle, the Children’s Hospital, the Meilahti Triangle
and Meilahti Tower Hospitals, the Women’s Hospital, the Eye and Ear Hospital, and the Department of Oncology. Concentration of the most demanding, specialist care in Meilahti is continued
in the plans for future construction work.
The Helsinki University Central Hospital
(HUCH) is part of the HUS joint municipal authority and responsible for organizing the most
complex and specialized care for the patients
of the Kymenlaakso and the Southern Carelia Hospital District as well. According to the
national plan, the HUCH hospitals are also responsible for organizing the care of all Finnish
patients with particularly demanding diseases. For example, all patients receiving an organ
transplant are treated at HUCH.
The annual budget of HUS is approximately
1.7 billion euros. The hospital district employs
professionals from approximately 21,000 distinct fields.
THE MEILAHTI CAMPUS 13
Haartman Hospital
www.hel.fi
The City of Helsinki’s Haartman Hospital is on the Meilahti Campus. The
hospital’s emergency department accepts patients 24 hours a day and
is visited by approximately 74,000 residents of Helsinki each year. Also,
the emergency dental care service point for the Helsinki Metropolitan
Area is at the Haartman Hospital.
Both routine health care and hospital emergencies are handled at
the Haartman Hospital. Furthermore, four hospital wards and an emergency and surveillance ward support the emergency services.
Future physicians and nurses are trained at the Haartman Hospital.
The annual budget of the Emergency Department is approximately
35 million euros. In all, there are 118 hospital beds and approximately
300 employees.
SAMULI SIREN, AMBULANCE DRIVER,
BRINGS A PATIENT TO HAARTMAN
HOSPITAL.
14 THE MEILAHTI CAMPUS
Folkhälsan
www.folkhalsan.fi
CELL CULTURE TECHNOLOGIES
PROVIDE IMPORTANT TOOLS
FOR BIOMEDICAL RESEARCH.
CAROLINE HECKMAN, SENIOR
RESEARCHER, IS CHECKING THE
STATUS OF HER CELL CULTURE.
Institute for Molecular
Medicine Finland
FIMM
Folkhälsan is a non-governmental organization in the social-welfare and health-care sector that promotes good health through activities
and education, and by providing health services
and conducting research.
In the past few years, its research operations have grown significantly. The various research groups operating at Folkhälsan’s research center employ, in total, 200 researchers
and other employees.
The research center’s activities focus on
biomedicine and public health, with three programs, in genetic research, preventive medicine, and public health research.
www.fimm.fi
Institute for Molecular Medicine Finland FIMM is an international research
institute focusing on the investigation of molecular mechanisms of diseases by applying genomics and medical systems biology. The research
work combines top-level studies and technology with unique patient and
biobank materials. The objective is to transfer data accumulated from research to practical health care by promoting the adoption of personalized
medicine, for example.
FIMM is part of the Nordic EMBL Partnership for Molecular Medicine,
alongside the European Molecular Biology Laboratory (EMBL) and the centers for molecular medicine in Norway and Sweden.
At the national level, FIMM is a joint research institute of the University
of Helsinki, the Hospital District of Helsinki and Uusimaa, the National Institute for Health and Welfare, and VTT Technical Research Centre of Finland.
The FIMM Technology Centre and biobanking services provide researchers with top expertise in the field and opportunities for national and international networking.
The annual budget comes to 14 million euros, with competitive external
funding accounting for close to 70% of this. The number of employees is approximately 170.
NINA RUOHO, LABORATORY
ASSISTANT, HAARTMAN
INSTITUTE AT THE
UNIVERSITY OF HELSINKI
THE MEILAHTI CAMPUS 15
POST-GRADUATE STUDENT VINCENT DUMONT
IS WORKING ON HIS DOCTORAL DISSERTATION
IN SANNA LEHTONEN’S RESEARCH GROUP AT
HAARTMAN INSTITUTE.
Minerva Foundation
Institute for Medical
Research
www.helsinki.fi/minerva
16 THE MEILAHTI CAMPUS
The Minerva Foundation Institute for Medical
Research is a private research institute focusing on the study of the mechanisms underlying major diseases, including cardiovascular
diseases, diabetes and neurological disorders,
and their cures through clinical and preclinical
examinations.
These activities are funded by the Minerva
Foundation (45%) and external sources (55%).
Approximately 50 researchers, researchers in
training, and assistants work as part of the eight
research groups. On average, five dissertations
are completed annually.
Helsinki Metropolia University
of Applied Sciences
Faculty of Health Care and Nursing
www.metropolia.fi/koulutusohjelmat/terveys-ja-hoitoala
Metropolia’s Faculty of Health Care and Nursing operates on the Meilahti Campus. The Faculty trains health-care professionals provides businesses and other organizations with lifetime learning services through the learning center TEHOSTA
and arranges research, development, and innovation activities promoting regional development.
The graduates have versatile health-care skills,
and they are familiar with evidence-based practices and capable of developing learning environment.
Degree programs include Biomedical Laboratory Science, Emergency Care , Nursing, Midwifery,
Public Health Nursing, Radiography and Radiotherapy, Oral Hygiene, and Master’s Programs in
Clinical Expertise, Development and Leadership in
Health Care and Social services, Health Promotion,
Health Business Management, and Emergency
and Critical Care Nursing. There are approximately
2,000 students and 180 members of staff at the
Faculty of Health Care and Nursing. Each year, approximately 500 new students are selected for
youth education studies and 200 to 250 for adult
education. Over 500 students graduate each year.
Helsinki University of Applied Sciences
Metropolia is owned by the cities of Helsinki, Espoo, Vantaa, and Kauniainen and the municipality of Kirkkonummi. The health-care and nursing
studies are organized in close cooperation with the
regional businesses.
JULIA GARAM, MARKE KUOSA AND JENNI SOINI
ARE STUDENTS OF EMERGENCY CARE AND
PRACTICE BELLOW MASK VENTILATION IN
THE SIMULATION LEARNING ENVIRONMENT
AT HELSINKI METROPOLIA UNIVERSITY OF
APPLIED SCIENCES.
HANNU LAITINEN, AMBULANCE DRIVER
STUDENT, AND LAURI RIIHIMÄKI, NURSE,
HAARTMAN HOSPITAL
THE MEILAHTI CAMPUS 17
Finnish Defence Force
Centre for Military Medicine
www.puolustusvoimat.fi
The Centre for Military Medicine acts as a service center, authority, and training center for the
Defence Forces’ medical service and conducts
unique studies in field medicine for national and
international use.
The Aeromedical Centre (AMC), CB Defence
and Environmental Health Centre (CBYK), and the
Defence Forces epidemiologist and occupational
health management group in charge of occupational health care for all defense-forces personnel are located at Biomedicum Helsinki.
ANNE ALÉN, NURSE, IS PREPARING FOR
HYPERBARIC OXYGEN THERAPY TESTING AT
THE AEROMEDICAL CENTRE OF THE CENTRE
FOR MILITARY MEDICINE.
18 THE MEILAHTI CAMPUS
AMC is in charge of the selection and periodic examinations of military pilots and the aeromedical examinations of other aviation personnel (military and civilian). The specialists at AMC
participate in the medical examinations of the
defense-forces personnel who assess qualification for military service.
CBYK operates as part of an international
network and has established a Center for Biological Threats in collaboration with the National
Institute for Health and Welfare.
EILA KORHONEN, SENIOR
LABORATORY TECHNICIAN,
BIOMEDICUM STEM CELL
CENTRE
National Institute for
Health and Welfare
www.thl.fi
The National Institute for Health and Welfare
(THL) prepares models of operation based on
research data for development of the health
and welfare system. THL aims to protect and
promote the health, functional capacity, and
welfare of the Finnish population; prevent diseases and social problems; reduce differences
in health and welfare between various socioeconomic groups; and support the development
of social and health policies. THL also participates in the prevention of biological and chemical threats.
The Public Health Genomics Unit (GETY) and
Immune Response Unit (ROIM) are found on the
Meilahti Campus, and the number of THL employees on the campus is around 90.
The total annual budget of the institute is 94
million euros. About 68% of this amount comes
from the state budget, 27% from external sources,
and 5% from service fees.
THE MEILAHTI CAMPUS 19
FOCUSING ON OCCUPATIONAL WELFARE POSITIVELY
AFFECTS THE COMPANY’S RESULT. A CHEERFUL
AND INSPIRING MEETING ROOM FREES ENERGY FOR
INNOVATION AND CREATIVITY. THE FINNISH INSTITUTE
OF OCCUPATIONAL HEALTH
Finnish Institute of
Occupational Health
www.ttl.fi
The Finnish Institute of Occupational Health
(FIOH) is a research and specialist organization
promoting occupational health and safety. FIOH
offers expert services, training, and information.
Its customers include experts in occupational
health and safety, decision-makers, employer
organizations, and private citizens.
The FIOH facilities house a national clinical
research unit for work-related diseases and assessments of work ability, and it operates as the
20 THE MEILAHTI CAMPUS
Clinic of Occupational Medicine of the Helsinki
University Central Hospital.
FIOH and THL collaborate in research and
development work within SOTERKO, a joint research venture with the Ministry of Social Affairs and Health.
FIOH acts as an expert institution in the field
of occupational health for the WHO and ILO.
About 55% of the annual budget comes from
the state, while 45% comes from commercial
operations and external research funding. Approximately 500 employees work on the Meilahti Campus.
IMAGES: EIJA HILTUNEN
TEXT COORDINATION: KIRSI VARMO
INTERVIEWS: IRMA HEISKANEN-HAARALA
GRAPHICS AND LAYOUT: PÄIVI TALONPOIKA-UKKONEN, UNIGRAFIA OY
PRINTING: UNIGRAFIA OY, 2012
PAPER: SCANDIA NATURAL, MAP SUOMI
COVER: PEKSKÄRMSMIKROSKOP, INNOVATION UTVECKLAD PÅ MEJLANS CAMPUS
Printed matter